Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 1/20 | 0.37 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13651150 | 1.00 | CA2 (0.50) | CA2ALDH1A1NPSR1CTDSP1HTR7 | |
| SCHEMBL18395904 | 0.93 | CA2 (0.56) | CA2ALDH1A1NPSR1CTDSP1HTR7 | |
| SCHEMBL6943821 | 0.93 | CA2 (0.56) | CA2ALDH1A1NPSR1CTDSP1HTR7 | |
| SCHEMBL7042446 | 0.87 | CA2 (0.53) | CA2ALDH1A1NPSR1CTDSP1HTR7 | |
| SCHEMBL6941294 | 0.86 | CA2 (0.49) | CA2ALDH1A1NPSR1CTDSP1HTR7 | |
| SCHEMBL30697976 | 0.86 | CA2 (0.49) | CA2ALDH1A1NPSR1CTDSP1HTR7 | |
| SCHEMBL13063460 | 0.85 | CA2 (0.51) | CA2ALDH1A1NPSR1HTR7TMEM97 | |
| SCHEMBL10441415 | 0.85 | CA2 (0.51) | CA2ALDH1A1NPSR1CTDSP1HTR7 | |
| SCHEMBL30401615 | 0.83 | CA2 (0.47) | CA2ALDH1A1NPSR1HTR7TMEM97 | |
| SCHEMBL461346 | 0.83 | CA2 (0.56) | CA2ALDH1A1NPSR1CTDSP1HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090253733-A1 | RAPAMYCIN CARBONATE ESTERS | BIOINTERACTIONS, LTD. (GB) | 2009-10-08 | — | — | US | claimed |
| US-5575944-A | Acetal-containing working fluid composition for refrigerating machine | KAO CORPORATION (JP) | 1996-11-19 | — | — | US | claimed |
| WO-2016012345-A1 | CYCLIC ACETAL DERIVATIVES AS ANTI-SOOT ADDITIVES FOR AN AVIATION FUEL | RHODIA OPERATIONS (FR) | 2016-01-28 | — | — | WO | disclosed |
| EP-2977433-A1 | Cyclic acetal derivatives as anti-soot additives for aviation fuel | Rhodia Opérations (FR) | 2016-01-27 | — | — | EP | disclosed |
| US-20090253733-A1 | RAPAMYCIN CARBONATE ESTERS | BIOINTERACTIONS, LTD. (GB) | 2009-10-08 | — | — | US | disclosed |
| WO-2009122176-A2 | RAPAMYCIN CARBONATE ESTERS | BIOINTERACTIONS LTD (GB) | 2009-10-08 | — | — | WO | disclosed |
| US-5575944-A | Acetal-containing working fluid composition for refrigerating machine | KAO CORPORATION (JP) | 1996-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253733-A1 | RAPAMYCIN CARBONATE ESTERS | CEL, MTOR, RICTOR | CA2 177/4885ALDH1A1 3975/4885NPSR1 3970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.